Generation Bio (GBIO) CFO Conway received 355,260 Stock Option (right to buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Kevin John Conway (Chief Financial Officer at Generation Bio Co., GBIO) reported that they received 355,260 Stock Option (right to buy) on Jan 10, 2025.
- Reporting person
- Conway Kevin John
- Role
- Chief Financial Officer
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jan 10, 2025 | Grant or award (A) | Stock Option (right to buy)On 355,260 Common Stock1 | +355,260 | - | - | 355,260 direct |
Holdings before and after
- Stock Option (right to buy): 0 to 355,260 direct
Footnotes from the filing
- 1. The option to purchase 355,260 shares was granted on January 10, 2025. The shares underlying the option vest over four years, with 25% of the shares vesting on January 10, 2026 and the remaining shares vesting in equal quarterly installments thereafter.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Conway report in this GBIO Form 4?
Kevin John Conway (Chief Financial Officer at Generation Bio Co., GBIO) reported that they received 355,260 Stock Option (right to buy) on Jan 10, 2025.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for GBIO
Earlier insider filings at GBIO
- Jan 14, 2025Director Quinn Anthony G. bought $203,209 worth of shares (210,791 units at $0.96), increasing direct ownership by 238% to 299,286 units (SEC Form 4)
- Jan 14, 2025SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Samayoa Phillip
- Jan 14, 2025SEC Form 4 filed by CHIEF OPERATING OFFICER Paone Antoinette
- Jan 14, 2025SEC Form 4 filed by PRESIDENT AND CEO Mcdonough Geoff
- Jan 14, 2025SEC Form 4 filed by CHIEF LEGAL OFFICER Howze Yalonda
Quantisnow market dataNASDAQ
GBIO
Generation Bio Co.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2020
Get push alerts for GBIO
Full GBIO profile on Quantisnow Follow GBIO and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time